Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1236-1247
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1236
Table 2 Clinical outcomes
Variables
Total (n = 102)
Best overall response
    CR10
    PR53
    SD20
    PD19
Objective response rate61.76%
Disease control rate81.37%
Median PFS10.07 months (95%CI: 8.50-11.65)
    6-month tumor PFS70.82% (95%CI: 60.80-78.72)
    12-month tumor PFS36.11% (95%CI: 26.49-45.79)
Median OS26.43 months (95%CI: 17.00-35.87)
    6-month survival92.63% (95%CI: 85.14-96.42)
    12-month survival84.15% (95%CI: 74.05-90.56)